Eligibility for long-acting cabotegravir/rilpivirine in youth aged 12-25 living with perinatally acquired HIV

被引：0
|
作者：
Ryan, Fionnuala [1 ]
Mackie, Nicola E. [2 ]
Jayadel, Hana [1 ]
Ayers, Sara [2 ]
Foster, Caroline [1 ,2 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Dept Paediat Infect Dis, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept GUM HIV Med, London, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O20
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
  • [2] An evaluation of long-acting cabotegravir plus rilpivirine for the treatment of virologically suppressed adults living with HIV
    Qazzaz, Hamdi
    Parganas, Christopher
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1485 - 1495
  • [3] Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
    Swindells, Susan
    Andrade-Villanueva, Jaime-Federico
    Richmond, Gary J.
    Rizzardini, Giuliano
    Baumgarten, Axel
    Masia, Mar
    Latiff, Gulam
    Pokrovsky, Vadim
    Bredeek, Fritz
    Smith, Graham
    Cahn, Pedro
    Kim, Yeon-Sook
    Ford, Susan L.
    Talarico, Christine L.
    Patel, Parul
    Chounta, Vasiliki
    Crauwels, Herta
    Parys, Wim
    Vanveggel, Simon
    Mrus, Joseph
    Huang, Jenny
    Harrington, Conn M.
    Hudson, Krischan J.
    Margolis, David A.
    Smith, Kimberly Y.
    Williams, Peter E.
    Spreen, William R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1112 - 1123
  • [4] Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV
    Taramasso, Lucia
    Bonora, Stefano
    Cingolani, Antonella
    Di Biagio, Antonio
    Gianotti, Nicola
    Guaraldi, Giovanni
    Lo Caputo, Sergio
    Madeddu, Giordano
    Maggi, Paolo
    Marchetti, Giulia
    Nozza, Silvia
    Rusconi, Stefano
    Maggiolo, Franco
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 610 - 623
  • [5] Off-label use of long-acting injectable cabotegravir/rilpivirine in viremic patient living with HIV
    Jorgensen, N. M.
    Larsen, L.
    HIV MEDICINE, 2023, 24 : 711 - 711
  • [6] Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
    Christopoulos, Katerina A.
    Hickey, Matthew D.
    Rana, Aadia
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 11 - 18
  • [7] COST-EFFECTIVENESS OF LONG-ACTING CABOTEGRAVIR PLUS LONG-ACTING RILPIVIRINE FOR THE TREATMENT OF HIV-1 IN TAIWAN
    Wen, Y. C.
    Ou, H. T.
    Tien, K.
    Harrison, C.
    Omonmhenle, D.
    Turner, M.
    Anderson, S. J.
    Jacob, I
    VALUE IN HEALTH, 2023, 26 (06) : S145 - S145
  • [8] Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials
    Patel, Parul
    Ford, Susan L.
    Baker, Mark
    Meyer, Claudia
    Garside, Louise
    D'Amico, Ronald
    Van Solingen-Ristea, Rodica
    Crauwels, Herta
    Polli, Joseph W.
    Seal, Ciara
    Yaguee Munoz, Itziar
    Thiagarajah, Shanker
    Birmingham, Eileen
    Spreen, William R.
    Baugh, Bryan
    van Wyk, Jean
    Vannappagari, Vani
    HIV MEDICINE, 2023, 24 (05) : 568 - 579
  • [9] Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
    Castelli, Alessandro
    Lanzafame, Massimiliano
    Morra, Matteo
    Bertoldi, Marco
    Delama, Andrea
    Fait, Daniela
    Vento, Sandro
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (05) : 283 - 285
  • [10] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman Living With Human Immunodeficiency Virus
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
12345